[製剤] Lonza Launches SimpliFiH™Services–an Integrated First-in-Human Service Package for Poorly Soluble Small Molecules

・Integrated drug substance, solid-statecharacterization, and phase-appropriate drug product provides simplified and accelerated route to first-in-humanstudies
・Proprietary bioavailability technology selection methodologies streamline solubility screening requirements
・Simplified agreement structures further facilitaterapid first-in-human timelines
（リンク先より全文をご覧いただけます/英語）

• リリース情報を見る